眼部颈动脉夹层市场规模、份额和成长分析：按诊断方法、临床症状、治疗方法、最终用户和地区划分－2026-2033年产业预测

2024 年全球眼颈动脉夹层市场价值为 130 亿美元，预计到 2033 年将从 2025 年的 136.5 亿美元增长到 201.7 亿美元，预测期（2026-2033 年）的复合年增长率为 5.0%。

全球眼部颈动脉夹层市场专注于诊断、介入器材和治疗，旨在解决因眼部血流受损而威胁视力的颈动脉壁撕裂问题。早期发现和早期疗育对于预防永久性视力丧失和降低中风风险至关重要。市场驱动因素包括人们对眼部症状血管病因的认识不断提高、影像技术的进步以及血管併发症患者老化加剧。市场正朝着精准的血管内和外科治疗方法方向发展，重点是颈动脉支架置放术和溶栓疗法的日益普及。微创器械的技术创新透过提高安全性和治疗可及性，推动了手术数量的成长，而个人化的诊断和治疗方案则创造了巨大的市场机会。人工智慧技术的进步正在改善影像解读和风险分层，简化工作流程，并增强病患管理策略。

全球眼部颈动脉夹层市场成长要素

影像技术的进步和临床医生专业技能的提升显着提高了对影响眼部血流的颈动脉夹层的早期准确检出率。诊断准确率的提高增强了医疗专业人员进行标靶干预和专科治疗的信心。影像诊断准确率的提高也推动了血管专家采用创新医疗设备和技术，因为这有助于选择创伤较小的治疗方法，并制定更有效率的治疗计划。因此，这一趋势推动了各种医疗机构对专门用于眼部颈动脉夹层诊疗的诊断工具和治疗方案的需求。

全球眼部颈动脉夹层市场的限制因素

全球眼颈动脉夹层市场面临许多挑战，其中最主要的原因是先进诊断技术、专用介入器材和手术全期护理的高成本。这些经济障碍不仅阻碍了医疗服务提供者，也为患者带来了许多不便，导致不同临床机构的诊疗规范化程度有限。在健保报销政策难以预测或不一致的情况下，医疗机构可能不愿投资于必要的培训和设备，以应对复杂的眼颈动脉夹层病例。这导致手术量减少，阻碍了市场成长。此外，人们普遍认为初始成本高于预期收益，这可能会进一步限制医疗机构的购买决策，并阻碍创新治疗方法和技术的广泛应用。

眼部颈动脉夹层的全球市场趋势

全球颈动脉夹层市场正经历一场重大变革，而远距眼科医疗的整合正是推动这项变革的关键因素。这一趋势透过促进远距筛检、影像共用以及血管和眼科多学科团队之间的协作，提高了早期发现和治疗的效率。虚拟平台透过加快分流流程、简化转诊至专科医生以及支援后续观察，消除了地理限制，使患者能够更便捷地获得医疗服务。与门诊诊所和当地医疗机构的合作对于涵盖医疗资源匮乏地区尤其重要。此外，改进的数位化工作流程和可互通的影像工具正在加强医疗协调，提高患者依从性，并确保医疗服务的连续性，最终实现及时干预和密切后续观察。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

关键市场分析

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场魅力指数
• PESTLE分析
• 监理情势

全球颈动脉夹层市场规模：依诊断方法划分

• MRA
• CTA
• 颈动脉双极超音波检查

全球颈动脉夹层市场规模：依临床症状划分

• 霍纳氏症候群的治疗
• 眼缺血症候群
• 颅神经麻痹

全球颈动脉夹层市场规模：依治疗性介入

• 抗凝血治疗/抗血小板治疗
• 血管内支架置入术
• 手术结扎/修復

全球眼颈动脉夹层市场规模：依最终用户划分

• 神经眼科诊所
• 中风和血管治疗单元
• 三级急诊医院

全球颈动脉夹层市场规模：按地区划分

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太国家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲国家

竞争资讯

• 前五大公司对比
• 主要企业2025年的市场定位
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市场占有率分析，2025 年
• 主要企业完整公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 销售收入年比比较（2023-2025 年）

主要企业简介

• GE HealthCare
• Siemens Healthineers
• Philips Healthcare
• Fujifilm Holdings
• Alcon Inc.
• Johnson & Johnson Vision
• Carl Zeiss Meditec
• Bausch+Lomb
• Glaukos Corp.
• Raumedic AG
• Medtronic
• Stryker
• Canon Medical Systems
• Nikon
• Topcon Corporation
• Heidelberg Engineering
• Haag-Streit
• EssilorLuxottica
• Hoya Corporation
• Nidek Co., Ltd.

结论与建议

Global Ocular Carotid Artery Dissection Market size was valued at USD 13.0 Billion in 2024 and is poised to grow from USD 13.65 Billion in 2025 to USD 20.17 Billion by 2033, growing at a CAGR of 5.0% during the forecast period (2026-2033).

The global ocular carotid artery dissection market focuses on diagnostics, interventional devices, and therapeutics addressing carotid artery wall tears that threaten vision through impaired ocular perfusion. Timely detection and intervention are critical in preventing permanent vision loss and reducing stroke risks. Key market drivers include heightened awareness of vascular causes of ocular symptoms, advancements in imaging technologies, and an aging population with vascular comorbidities. The market has progressed towards precise endovascular and surgical methods, emphasizing the increased usage of carotid stenting and thrombolysis. Technological innovations in minimally invasive devices are fostering higher procedure volumes by enhancing safety and treatment accessibility, while tailored diagnostic and therapeutic options are generating significant market opportunities. As AI technologies advance, they are enhancing imaging interpretation and risk stratification, streamlining workflows, and improving patient management strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ocular Carotid Artery Dissection market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ocular Carotid Artery Dissection Market Segments Analysis

Global ocular carotid artery dissection market is segmented by diagnostic modality, clinical presentation, treatment intervention, end-user and region. Based on diagnostic modality, the market is segmented into MRA, CTA and Carotid Duplex Ultrasonography. Based on clinical presentation, the market is segmented into Horner's Syndrome Management, Ocular Ischemic Syndrome and Cranial Nerve Palsies. Based on treatment intervention, the market is segmented into Anticoagulation/Antiplatelet Therapy, Endovascular Stenting and Surgical Ligation/Repair. Based on end-user, the market is segmented into Neuro-Ophthalmology Clinics, Stroke & Vascular Units and Tertiary Emergency Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Ocular Carotid Artery Dissection Market

Advancements in diagnostic imaging technologies and heightened clinician expertise are significantly enhancing the early and precise detection of carotid artery dissections that impact ocular blood flow. This increase in diagnostic accuracy bolsters healthcare professionals' confidence in implementing targeted interventions and specialized therapies. Improved visualization aids in the choice of less invasive treatment options and streamlines procedural planning, promoting the uptake of innovative devices and techniques among vascular specialists. Consequently, this trend boosts the demand for both diagnostic tools and therapeutic solutions specifically designed for managing ocular carotid artery dissections across various healthcare environments.

Restraints in the Global Ocular Carotid Artery Dissection Market

The Global Ocular Carotid Artery Dissection market faces notable challenges due to the high costs linked to advanced diagnostic techniques, specialized interventional tools, and perioperative care. These financial hurdles create obstacles for both healthcare providers and patients, resulting in limited standardization of practices across various clinical settings. In environments where reimbursement policies are unpredictable or inconsistent, institutions may hesitate to invest in essential training and equipment needed for addressing complex ocular carotid artery dissections. Consequently, this leads to reduced procedure volumes, inhibiting market growth. Additionally, the perception of high initial expenses compared to the expected incremental benefits can further restrict purchasing decisions and impede the broader adoption of innovative therapies and technologies.

Market Trends of the Global Ocular Carotid Artery Dissection Market

The Global Ocular Carotid Artery Dissection market is experiencing a significant shift driven by the integration of teleophthalmology. This trend is enhancing early detection and management by facilitating remote screening, image sharing, and collaboration among multidisciplinary teams in vascular and eye care. Virtual platforms accelerate triage processes, simplify referrals to specialists, and support follow-up monitoring, thereby removing geographic barriers to access. The collaboration with ambulatory clinics and community providers is particularly crucial for reaching underserved areas. Furthermore, improved digital workflows and interoperable imaging tools are fostering better care coordination, enhancing patient adherence, and ensuring continuity of care, ultimately enabling timely interventions and closer surveillance.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Ocular Carotid Artery Dissection Market Size by Diagnostic Modality & CAGR (2026-2033)

• Market Overview
• MRA
• CTA
• Carotid Duplex Ultrasonography

Global Ocular Carotid Artery Dissection Market Size by Clinical Presentation & CAGR (2026-2033)

• Market Overview
• Horner's Syndrome Management
• Ocular Ischemic Syndrome
• Cranial Nerve Palsies

Global Ocular Carotid Artery Dissection Market Size by Treatment Intervention & CAGR (2026-2033)

• Market Overview
• Anticoagulation/Antiplatelet Therapy
• Endovascular Stenting
• Surgical Ligation/Repair

Global Ocular Carotid Artery Dissection Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Neuro-Ophthalmology Clinics
• Stroke & Vascular Units
• Tertiary Emergency Hospitals

Global Ocular Carotid Artery Dissection Market Size & CAGR (2026-2033)

• North America (Diagnostic Modality, Clinical Presentation, Treatment Intervention, End-User)
  • US
  • Canada
• Europe (Diagnostic Modality, Clinical Presentation, Treatment Intervention, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Diagnostic Modality, Clinical Presentation, Treatment Intervention, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Diagnostic Modality, Clinical Presentation, Treatment Intervention, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Diagnostic Modality, Clinical Presentation, Treatment Intervention, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• GE HealthCare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Vision
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss Meditec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch + Lomb
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glaukos Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Raumedic AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikon
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Topcon Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heidelberg Engineering
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haag-Streit
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EssilorLuxottica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoya Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nidek Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations